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Abstract
Introduction:  Adenotonsillar  hyperplasia  (ATH)  and  allergic  rhinitis  (AR)  are  the  most  com-
mon causes  of  upper  airway  obstruction  in  children.  Such  diseases,  by  affecting  the  upper
airways,  can  cause  chronic  alveolar  hypoventilation,  pulmonary  vasoconstriction  and  pulmonary
hypertension,  which  in  some  cases,  are  irreversible.Doppler
echocardiography;
Rhinitis
Objective:  This  cross-sectional  study  aimed  to  evaluate  the  prevalence  of  pulmonary  hyper-
tension in  two  groups  of  mouth-breathing  (MB)  2--12  year  old  children  with  ATH  and  isolated
allergic rhinitis,  through  Doppler  echocardiography.
 Please cite this article as: Lima MS, Nader CM, Franco LP, Meira ZM, Capanema FD, Guimarães RE, et al. Pulmonary hyperten-
sion evaluation by Doppler echocardiogram in children and adolescents with mouth breathing syndrome. Braz J Otorhinolaryngol. 2016.
http://dx.doi.org/10.1016/j.bjorl.2016.03.020
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Methods:  54  patients  with  ATH  and  indications  for  adenoidectomy  and/or  tonsillectomy  and  24
patients  with  persistent  allergic  rhinitis  were  selected  and  submitted  to  Doppler  echocardiog-
raphy. The  Systolic  Pulmonary  Artery  Pressure  (SPAP)  was  determined  by  tricuspid  regurgitation
and the  Mean  Pulmonary  Artery  Pressure  (MPAP)  was  calculated  from  the  SPAP.  Similar  measure-
ments were  carried  out  in  25  nasal  breathing  (NB)  individuals.
Results:  The  mean  MPAP  and  SPAP  were  higher  in  the  MB  than  in  the  NB  group  (17.62  ±  2.06
[ATH] and  17.45  ±  1.25  [AR]  vs.  15.20  ±  2.36  [NB]  mmHg,  p  <  0.005,  and  25.61  ±  3.38  [ATH]  and
25.33 ±  2.06  [AR]  vs.  21.64  ±  3.87  [NB]  mmHg,  p  <  0.005,  respectively)  and  the  mean  accelera-
tion time  of  pulmonary  ﬂow  trace  (Act)  was  higher  in  the  NB  than  in  the  MB  group  (127.24  ±  12.81
[RN] vs.  114.06  ±  10.63  ms  [ATH]  and  117.96  ±  10.28  [AR]  MS  [AR];  p  <  0.0001).
Conclusion:  None  of  the  MB  children  (ATH  and  AR)  met  the  PH  criteria,  although  individuals  with
both ATH  and  isolated  AR  showed  signiﬁcant  evidence  of  increased  pulmonary  artery  pressure  by
Doppler echocardiography  in  relation  to  NB  individuals.  No  differences  were  observed  between
the ATH  and  AR  groups.
©  2016  Published  by  Elsevier  Editora  Ltda.  on  behalf  of  Associac¸a˜o  Brasileira  de  Otorrino-
laringologia  e  Cirurgia  Ce´rvico-Facial.  This  is  an  open  access  article  under  the  CC  BY  license
(http://creativecommons.org/licenses/by/4.0/).
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Avaliac¸ão  de  hipertensão  pulmonar  pela  Ecodopplercardiograﬁa  em  crianc¸as e
adolescentes  com  síndrome  do  respirador  oral
Resumo
Introduc¸ão:  A  Hiperplasia  Adenotonsilar  (HAT)  e  a  Rinite  Alérgica  (RA)  consistem  nas  causas  mais
comuns de  obstruc¸ão  de  vias  aéreas  superiores  em  crianc¸as.  Tais  afecc¸ões  ao  comprometer  a  via
aérea superiores  podem  ocasionar  hipoventilac¸ão  alveolar  crônica,  vasoconstric¸ão  pulmonar  e
hipertensão pulmonar,  em  alguns  casos,  irreversível.
Objetivo:  este  estudo  transversal  objetivou  avaliar  a  prevalência  de  hipertensão  arterial  pul-
monar em  dois  grupos  de  crianc¸as  Respiradoras  Orais  (RO):  com  HAT  e  rinite  alérgica  isolada,
de 2  a  12  anos  de  idade,  por  meio  de  exame  ecodopplercardiográﬁco.
Método:  54  pacientes  com  HAT  com  indicac¸ão  de  adenoidectomia  e/ou  tonsilectomia  e
24 pacientes  com  rinite  alérgica  persistente  foram  selecionados  e  submetidos  à  ecodoppler-
cardiograﬁa.  A  Pressão  Sistólica  da  Artéria  Pulmonar  (PSAP)  foi  determinada  pela  regurgitac¸ão
tricúspide e  a  Pressão  Média  da  Artéria  Pulmonar  (PMAP)  foi  calculada  a  partir  da  PSAP.
Determinac¸ões similares  foram  realizadas  em  25  Respiradores  Nasais  (RN).
Resultados:  as  médias  da  PMAP  e  da  PSAP  foram  maiores  nos  grupos  de  RO  do  que
nos RN  (17,62  ±  2,06  [HAT]  e  17,45  ±  1,25  [RA]  vs.  15,20  ±  2,36  [RN]  mmHg;  p  <  0,005;  e
25,61 ±  3,38  [HAT]  e  25,33  ±  2,06  [RA]  vs.  21,64  ±  3,87  [RN]  mmHg;  p  <  0,005;  respectivamente)
e a  média  do  tempo  de  acelerac¸ão  do  trac¸ado  do  ﬂuxo  pulmonar  (TAc)  foi  maior  nos  RN  que  nos
grupos de  RO  (127,24  ±  12,81  [RN]  vs.  114,06  ±  10,63  ms  [HAT]  e  117,96  ±  10,28  [RA]  MS  [RA];
p <  0,0001).
Conclusão:  Nenhuma  crianc¸a  respiradora  oral  (HAT  e  RA)  preencheu  os  critérios  de  HP  embora
tanto os  portadores  de  HAT  quanto  de  RA  isolada  apresentaram  evidências  signiﬁcativas  de
aumento  da  pressão  arterial  pulmonar  pela  ecodopplercardiograﬁa  em  relac¸ão  aos  respiradores
nasais. Não  se  observou  diferenc¸a  entre  os  grupos  HAT  e  RA.
© 2016  Publicado  por  Elsevier  Editora  Ltda.  em  nome  de  Associac¸a˜o  Brasileira  de  Otorrino-
laringologia  e  Cirurgia  Ce´rvico-Facial.  Este e´  um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY
(http://creativecommons.org/licenses/by/4.0/).
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introduction
outh  breathing  syndrome  (MBS)  refers  to  the  clinical
ondition  in  which  the  individual  has  a  breathing  pattern
erformed  predominantly  through  the  oral  cavity  for  a
eriod  longer  than  six  months.1,2 Among  the  etiologies,  aller-
ic  rhinitis  is  the  most  common  cause  of  chronic  upper
irway  obstruction  (UAO),3 accounting  for  up  to  85%  of
t
a
vases.  The  hypertrophy  of  adenoids  and/or  tonsils  corre-
ponds  to  79.2%,  being  the  main  cause  of  Obstructive  Sleep
pnea  (OSA)  in  children.1,4--9
Chronic  nasal  obstruction  and  the  consequent  OBS  result
n  an  insufﬁcient  supply  of  oxygen  and  alveolar  ventila-
ion  during  the  night,  causing  hypoventilation,  hypoxemia
nd  hypercapnia  that  can  lead  to  OSA  and  pulmonary
asoconstriction,  which,  if  persistent,  results  in  pulmonary
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Pulmonary  hypertension  evaluation  by  Doppler  echocardiogr
hypertension  (PH).6--14 PH  in  children  is  deﬁned  as  Mean
Pulmonary  Artery  Pressure  (MPAP)  ≥25  mmHg  or  Systolic
Pulmonary  Artery  Pressure  (SPAP)  ≥35  mmHg  at  rest.6,15
Although  there  are  few  reports  of  severe  manifestations
such  as  cor  pulmonale  and  death,16--21 PH  in  its  initial  phase
has  been  very  prevalent  in  some  studies  involving  up  to
84%  of  mouth  breathers  (MB).11 Nevertheless,  underdiag-
nosis  is  observed  in  the  initial  phase  of  PH  due  to  the
scarcity  of  cardiovascular  symptoms.11 An  early  approach,
with  adenotonsillectomy  and  treatment  of  allergic  rhini-
tis,  promptly  reverses  elevated  pressures  in  the  pulmonary
artery.6--9,12--14,22
The  Doppler  echocardiographic  evaluation  is  a  non-
invasive  method  that  allows  the  estimation  of  the  MPAP
and  SPAP  values  with  a  sensitivity  of  79--100%  and  a
speciﬁcity  of  68--98%.15,23 In  spite  of  its  low-cost  and  poten-
tial  for  an  early  assessment  of  cardiac  complications,  it
is  not  routinely  performed  in  patients  with  UAO,  being
restricted  to  severe  cases  of  OSA  with  evident  cardiovascular
deterioration.6,7,9,12,13
This  study  aimed  to  evaluate  the  presence  of  PH  in  MB
with  UAO  caused  by  ATH  and  AR  in  children  and  adolescents
treated  in  a  referral  center  through  the  Doppler  echocardi-
ographic  method.
Methods
This  study  was  approved  by  the  Research  Ethics  Committee
(CAAE  number:  20931213.0.0000.5149).  The  patients  were
informed  about  the  study  and  its  objectives  and  were  asked
to  sign  the  free  and  informed  consent  form,  after  assisted
reading  and  guidance.
The  sample  consisted  of  children  and  adolescents  aged
two  to  twelve  years,  MB  with  ATH  and  AR,  treated  as  ﬁrst
consultation  at  the  Mouth  Breather  Outpatient  Clinic,  in
addition  to  patients  with  no  MB  complaints,  treated  at  the
pediatric  and  speech  therapy  outpatient  clinic  for  other
complaints  that  were  allocated  in  the  nasal  breather  (NB)
group.
Patient  sample  size  was  calculated  using  two  compara-
tive  studies12,13 involving  two  proportions:  the  comparison
of  pulmonary  hypertension  (PH)  prevalence  in  the  MB
versus  the  prevalence  of  PH  in  the  NB  group.  Consid-
ering  the  prevalence  of  10%12 in  NB  and  60%13 or  more
in  MB,  in  order  to  detect  differences  between  the  two
groups  in  at  least  50%  (˛  =  0.05  and  ˇ  =  0.10),  it  would
be  necessary  to  have  at  least  21  patients  in  each
group.
At  the  selection  procedure,  patients  underwent  anam-
nesis,  complete  otorhinolaryngological  examination,  aller-
gologic  evaluation  with  skin  test  puncture  and  a  multidis-
ciplinary  evaluation  (physical  therapist,  orthodontist  and
speech  therapist).  Together  with  the  subjective  evalua-
tion  of  nasal  obstruction,  all  patients  underwent  anterior
active  rhinomanometry  (RAA)  and  Doppler  echocardiogra-
phic  assessment.  Patients  who  met  the  following  criteria
were  selected:
Inclusion  criteria  --  We  included  MB  patients  with
tonsillar  hyperplasia  grade  III  or  IV  and/or  adenoid  hyper-
plasia  with  nasopharynx  obstruction  ≥75%,24 conﬁrmed  by
h
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torhinolaryngological  examination  and  ﬁbronasopharyngo-
aryngoscopy  (ATH  group)  and  clinical  diagnosis  of  rhinitis
ith  positive  skin  test  (AR  group).
 ATH  group:  mouth  breathing  children  with  hyperplasia
of  the  palatine  tonsil  grade  III  and  grade  IV  and/or
adenoid  hyperplasia  with  nasopharynx  obstruction  ≥75%,
conﬁrmed  by  otorhinolaryngological  examination  and
ﬁbronasopharyngolaryngoscopy,  with  or  without  positive
skin  test;
 AR  group:  mouth  breathing  children  without  obstructive
adenotonsillar  hyperplasia  and  with  nasal  hyperreactivity
and  positive  skin  test;
 NB  group:  nasal  breathing  children  without  adenotonsillar
hyperplasia  and  negative  skin  test.
Exclusion  criteria  --  Patients  with  heart  disease;  pre-
ious  craniofacial  and  respiratory  system  surgeries;  skin
esions  that  prevented  the  performance  of  skin  allergic  test
SAT);  respiratory  infection  in  the  upper  and  low  respira-
ory  tracts  in  the  last  14  days;  chronic  comorbidities;  to  be
sing  or  having  used  the  following  medications:  intranasal
orticosteroids,  anticholinergics,  systemic  or  topical  vaso-
onstrictor,  nasal  cromolyn  or  other  nasal  decongestant  in
he  past  four  weeks;  antihistamines  in  the  last  two  weeks;
ral  corticosteroids  and  leukotriene  receptor  antagonist  in
he  last  eight  weeks;  speciﬁc  immunotherapy  in  the  past  3
onths;  and  those  who  did  not  sign  the  free  and  informed
onsent  (FIC)  form  were  excluded.4,9,12,25--27
perational  deﬁnitions
he  study  consisted  of  three  stages:  1  --  selection  of  MB  and
B  in  pediatric  clinics  and  referral  to  the  specialized  cen-
er;  2  --  evaluation  of  referrals  for  diagnostic  conﬁrmation  or
xclusion  of  the  OBS  and  for  etiological  diagnosis  and  classiﬁ-
ation  of  ATH;  3  --  performing  the  Doppler  echocardiography
o  diagnose  PH.
All  patients,  MB  and  NB,  were  submitted  to  com-
lete  otorhinolaryngological  examination,  allergy  skin  test,
bronasopharyngolaryngoscopy  and  active  anterior  rhinom-
try.  Tonsil  size  was  classiﬁed  according  to  the  Brodsky’s
riteria,27 considering  the  degree  of  oropharyngeal  obstruc-
ion.  Adenoid  hyperplasia  was  rated  by  nasal  endoscopy
ccording  to  the  percentage  of  choanal  lumen  obstruction
egree.1,24
All  patients  underwent  Doppler  echocardiography  with
olor  ﬂow  mapping  using  Phillips® IE  33  device.  For  the
PAP  analysis,  tricuspid  regurgitation  measurement  was
erformed  using  the  apical  window  in  the  apical  four-
hamber  view,  measuring  systolic  peak  velocity  and  using
ernoulli’s  formula;  the  MPAP  estimate  was  performed  using
he  formula:  MPAP  =  0.61  ×  SPAP  +  2  mmHg28; in  addition  to
he  calculation  of  the  time  of  acceleration  of  the  pulmonary
ow  (TAc),  by  measuring  the  interval  between  the  beginning
nd  the  peak  of  the  pulmonary  ﬂow  wave.  All  measure-
ents  were  performed  by  calculating  the  average  of  three
eartbeats  and  the  examinations  were  carried  out  by  two
chocardiographers  experienced  in  the  method,  without
nowledge  of  the  patients’  clinical  data.  The  upper  limit  of
PAP  was  considered  as  25  mmHg  and  SPAP  as  35  mmHg.6,15
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Table  1  Demographic  and  anthropometric  data.
NB  (n  =  25)  ATH  (n  =  54)  AR  (n  =  24)
Mean  (SD)  Mean  (SD)  Mean  (SD)
Male  gender  (%/n)  32.0%  8  57.4%  31  58.3%  14
Age (years)a 7.30  (2.47)  6.04b (2.24)  7.42  (2.05)
Weight (kg) 27.92  (11.07)  22.83  (8.20)  25.36  (8.79)
Height (m)a 1.27 (0.17)  1.15b (0.15)  1.23  (0.15)
BMI (kg/m2) 16.24 (2.77)  16.57 (2.63)  16.08  (2.18)
a Statistically signiﬁcant difference between group with AR and group with ATH (p < 0.05).
b Statistically different from the NB group (p < 0.05).
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phe  echocardiographers  were  unaware  of  which  group  the
atient  belonged  to.
nalyzed  variable
PAP  and  SPAP
ccording  to  the  recommendations  of  the  ‘‘Guidelines  for
he  diagnosis  and  treatment  of  pulmonary  hypertension’’,15
H  consists  in  MPAP  ≥  25  mmHg.  When  MPAP  is  between
0  mmHg  and  24  mmHg,  an  altered  MPAP  is  considered,  but
s  we  do  not  know  the  signiﬁcance  of  its  clinical  impact,
t  is  not  considered  as  PH.  The  value  for  SPAP  ≥  35  mmHg
s  also  considered  diagnostic  in  some  studies,  as  well  as
Ac  ≤  100  ms.12,28
tatistical  analysis
ategorical  data  are  shown  as  numbers  and  percentages,
nd  continuous  data  as  mean  and  standard  deviation.  Cat-
gorical  variables  of  patients  and  controls  were  compared
sing  the  chi-square  test.  Continuous  variables  were  ana-
yzed  by  Student’s  t  test.  Comparisons  between  the  study
roups  were  carried  out  through  bilateral  hypothesis  tests
onsidering  a  signiﬁcance  level  of  5%  (=0.05).
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Table  2  Data  obtained  from  the  history  and  physical  examinatio
NB  (n  =  25)  
%  n  
Asthmaa 4.0%  1  
+Skin testa 0.0%  0  
Snoring 0.0%  0  
Apnea 0.0%  0  
Bruxism 28.0%  7  
Headache 28.0%  7  
% R  Adenoid  (mean/SD)a 11.8%  (15.1%)  
% L  Adenoid  (mean/SD)a 12.2%  (15.4%)  
R tonsillar  gradea I:  18;  II:  7;  III:  0;  IV:  0  
L tonsillar  gradea I:  17;  II:  8;  III:  0;  IV:  0  
a Statistically signiﬁcant difference between group with AR and grou
b Statistically different from the NB group (p < 0.05).
Tonsillar grade -- I < 25% II ≥ 25% and <50% III ≥ 50% and <75%, IR ≥ 75%.esults
he  study  population  consisted  of  54  chronic  mouth
reathers  with  ATH  and  surgical  indication  for  adenoidec-
omy  and/or  tonsillectomy  (31  males,  with  a  mean  age  of
.04  ±  2.24  years  and  mean  BMI  of  16.57  ±  2.63)  and  24
atients  with  persistent  AR  (14  males,  with  a mean  age  of
.42  ±  2.05  years  and  mean  BMI  of  16.08  ±  2.18)  compared
o  25  healthy  patients  without  UAO.  There  was  a  statisti-
ally  signiﬁcant  difference  in  age  and  height,  with  the  mean
eight  and  age  being  lower  in  the  ATH  group.  However,  there
ere  no  signiﬁcant  differences  in  gender,  weight  and  body
ass  index  (BMI)  (Table  1).
Regarding  the  history  obtained  at  the  referral  outpatient
linic  and  directed  to  parents  and/or  guardians  of  the  MB
bout  the  behavior  of  their  children  during  sleep,  all  of  them
eported  mouth  breathing.  Among  the  complaints  related
o  OSA,  all  patients  with  adenotonsillar  hypertrophy  and
9  patients  (79.2%)  from  the  rhinitis  group  complained  of
noring,  while  breathing  pauses  suggestive  of  apnea  were
revalent  in  62.7%  and  39.1%  in  the  ATH  and  AR  groups,
espectively.  Regarding  adenoid  hyperplasia  with  indication
or  adenoidectomy,  42  patients  (77.7%)  had  adenoids  occu-
ying  75%  or  more  of  the  nasopharynx,  and  17  (31.4%)  had
denoids  occupying  90%  or  more.  Allergic  rhinitis  with  a
n  of  patients  at  the  ﬁrst  consultation  at  the  referral  clinic.
ATH  (n  =  54)  AR  (n  =  24)
%  n  %  n
19.6%b 10  50.0%b 12
35.3%b 18  100.0%b 24
96.2%b 51  79.2%b 19
62.7%b 32  39.1%b 9
42.0%  21  50.0%  12
38.9%  21  29.2%  7
76.7%b (19.2%)  19.2%  (14.8%)
76.4%b (17.9%)  19.0%  (14.7%)
I:  7;  II:  11;  III:  24;  IV:  12b I:  13;  II:  10;  III:  1;  IV:  0
I:  7;  II:  8;  III:  24,  IV:  15b I:  15;  II:  9;  III:  0;  IV:  0
p with ATH (p < 0.05).
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Table  3  Mean  values  of  SPAP,  MPAP  and  TAc.
NB  (n  =  25)  ATH  (n  =  54)  AR  (n  =  24)
Mean (SD)  Mean  (SD)  Mean  (SD)
SPAP  (mmHg)  21.64  (3.87)  25.61a (3.38)  25.33a (2.06)
MPAP (mmHg)  15.20  (2.36)  17.62a (2.06)  17.45a (1.25)
TAc (mmHg)  127.24  (12.81)  114.06a (10.63)  117.96a (10.28)
a Statistically different from the NB group (p < 0.05).
 Statistically signiﬁcant difference between the AR group and group w
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9,10Figure  1  Box  plot  graph  showing  the  association  between  the
SPAP in  the  MB  and  NB  groups.
positive  skin  test  was  detected  in  18  (35.3%)  patients  with
ATH  (Table  2).
Among  the  echocardiographic  ﬁndings,  we  observed  a  dif-
ference  regarding  MPAP  and  SPAP,  being  higher  in  the  MB  than
the  NB  group  (17.62  ±  2.06  (ATH)  and  17.45  ±  1.25  (AR)  vs.
15.20  ±  2.36  and  25.61  ±  3.38  mm  Hg  (ATH)  and  25.33  ±  2.06
(AR)  vs.  21.64  ±  3.87  mmHg,  p  <  0.005,  respectively),  while
TAc  was  higher  in  NB  (127.4  ±  12.81  vs.  114.06  ±  10.63  ms
(ATH)  and  117.96  ±  10.28,  p  <  0.0001).  There  was  no  signiﬁ-
cant  difference  between  SPAP,  MPAP  and  TAc  values  among
mouth  breathers  when  considering  the  different  etiologies,
ATH  and  AR  (Table  3).
No  child  had  PH  at  the  echocardiography.  Seven  patients
with  ATH  (12%)  had  MPAP  ≥  20  mmHg,  but  none  had
MPAP  ≥  25  mmHg.  The  rhinitis  group  and  NB  group  had  a
patient  with  MPAP  ≥  20  mmHg  each.  TAc  ranged  from  84  to
136  ms  in  the  ATH  group,  from  96  to  142  ms  in  patients
with  AR  and  100  to  146  ms  in  the  group  of  nasal  breathers.
TAc  ≤  100  ms  was  found  in  six  patients  with  adenotonsillar
hypertrophy  (11%),  in  one  patient  of  the  NB  group  and  in  one
patient  of  the  AR  group.  SPAP  ranged  from  19  to  32  mmHg
in  patients  from  the  ATH  group  and  from  22  to  32  in  the
AR  group,  whereas  in  the  NB  group  SPAP  ranged  from  16  to
30  mmHg  (Fig.  1).Discussion
In  this  study,  statistically  signiﬁcant  differences  were
observed  between  the  oral  and  nasal  breathers  in  relation
f
m
t
pith ATH (p < 0.05).
o  PH  measures  (SPAP,  MPAP  and  TAc),  which  indicate  the
isk  of  development  of  future  irreversible  cardiopulmonary
omplications.  However,  no  patient  had  a  diagnosis  of  PH,
ontrary  to  what  is  described  in  the  literature.
Naiboglu  et  al.  assessed  the  change  in  Pulmonary  Artery
ressure  (PAP)  in  children  with  adenotonsillectomy  indica-
ion  compared  to  a  control  group.  Of  the  39  patients  with
pper  airway  obstruction,  84%  were  considered  hypertensive
ue  to  increased  MPAP,  whereas  in  the  control  group  only  two
atients  were  classiﬁed  as  hypertensive.  However,  the  used
utoff  value  was  20  mmHg  and  the  calculation  of  MPAP  was
erformed  through  TAc,  which  is  an  unreliable  parameter
hen  it  is  not  corrected  by  the  heart  rate.12
In  a  study  carried  out  by  Yilmaz13 et  al.  (2005),  52  children
ere  randomly  selected,  aged  between  4  and  11  years,  with
he  diagnosis  of  UAO  secondary  to  ATH  and  33  children  in  the
ontrol  group.  MPAP  levels  were  compared  between  cases
nd  controls,  and  the  ﬁrst  group  had  signiﬁcantly  higher
lood  pressure  levels  (MPAP  of  23.13  ±  7.68  in  cases  and
6.11  ±  7.24  in  controls).
As  in  the  Naiboglu  work,  Yilmaz  et  al.  classiﬁed  as  hyper-
ensive  those  patients  with  MPAP  >  20  mmHg.  However,  the
revalence  of  PH  was  lower  with  the  involvement  of  51%  of
atients  with  adenotonsillectomy  indication,  compared  to
%  in  the  control  group.  Both  studies  evaluated  the  reversal
f  MPAP  values  after  the  adenotonsillectomy  and  found  sim-
lar  pressure  values  to  those  in  the  control  group  after  the
rocedure.12,13
In  addition  to  the  aforementioned  studies,  a  recent  one
y  Martha  et  al.  analyzed  SPAP  and  MPAP  values  in  33  chil-
ren  with  adenotonsillar  hypertrophy  and  compared  them
ith  10  control  patients.  The  diagnosis  of  PAH  was  achieved
hrough  Doppler  echocardiographic  evaluation  and  patients
ith  SPAP  ≥  30  mmHg  or  MPAP  ≥  25  mmHg  were  considered
ypertensive.  The  prevalence  of  hypertension  was  36%  in  the
TH  group,  a  lower  value  than  in  other  studies.  The  evalua-
ion  of  systolic  pressure  was  made  by  tricuspid  regurgitation,
hereas  in  patients  without  this  regurgitation,  MPAP  was  cal-
ulated  from  TAc.  In  the  group  of  19  patients  in  which  the
valuation  was  performed  by  the  Mahan  formula,  a  calcu-
ation  that  depends  on  the  TAc  value,  the  prevalence  of  PH
as  higher.6
In  contrast  to  the  aforementioned  studies,  the  present
tudy  also  assessed  the  impact  of  allergic  rhinitis  on  pul-
onary  pressure  and  compared  the  ﬁndings  to  the  group
ith  adenotonsillar  hypertrophy.  Although  there  have  been
ew  studies  on  AR  and  PH, we  can  demonstrate  that  the
ean  pulmonary  pressure  is  high  in  rhinitis  and  comparable
o  those  in  patients  with  signiﬁcant  adenotonsillar  hypertro-
hy.
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The  association  between  allergic  rhinitis  (AR)  and  pul-
onary  hypertension  was  also  evaluated  in  a  study  with
5  patients  that  correlated  symptom  severity  with  changes
n  echocardiography  in  patients  with  seasonal  allergic
hinitis.  The  literature  showed  an  increase  in  PAP  during
atients’  symptomatic  periods,  with  a  reduction  in  PAP  val-
es  during  the  asymptomatic  period.  The  symptom  that
howed  a  higher  correlation  with  PAP  results  was  nasal
bstruction  severity,  indicating  a  previously  discussed  asso-
iation  of  nasal  resistance  increase  with  cardiopulmonary
lterations.10
Some12 studies  use  TAc  to  evaluate  PH  with  the  refer-
nce  value  (limit  of  normality)  of  100  ms.  This  method  is
ften  used  in  adults,  but  has  limitations  in  children  with
levated  heart  rate,  as  it  can  signiﬁcantly  inﬂuence  the  pat-
ern  of  the  outﬂow  tract  velocity  curve  and  the  acceleration
ime.  Therefore,  other  methods  are  recommended,  particu-
arly  those  using  continuous  Doppler,  since  it  allows  indirect
easurement  of  the  Systolic  Pulmonary  Artery  Pressure  by
ssessing  tricuspid  regurgitation.29 In  the  present  study,  we
sed  the  measure  derived  from  tricuspid  regurgitation,  the
ost  recommended  method  and  the  one  with  lower  inter
nd  intraobserver  variability.
This  study  is  relevant  for  the  literature,  as  it  can  inﬂu-
nce  clinical  practice  through  a  new  approach  proposal  for
B,  in  addition  to  warn  against  cardiopulmonary  risks  that
re  not  as  yet  well  established.  The  care  of  patients  with
AO  should  not  focus  only  on  patients  with  ATH,  as  changes
n  pulmonary  pressure  were  comparable  in  patients  with  ATH
nd  AR.  Thus,  the  early  identiﬁcation  of  patients  at  risk  for
H  is  important,  as  it  is  directly  related  to  prognosis  because
f  the  potential  reversibility  of  the  picture,  when  correc-
ive  surgical  procedure  and/or  drug  treatment  indication  are
arried  out  in  a  timely  manner.6,9,12,13
onclusion
lthough  no  MB  in  the  assessed  sample  was  diagnosed  with
H,  both  SPAP  and  MPAP,  measured  by  Doppler  echocardi-
graphy,  showed  increased  means  when  compared  to  nasal
reathers,  i.e.,  the  normal  standard.  This  fact  may  pose  a
reater  risk  for  future  heart  complications  in  patients  with
BS.
Patients  with  allergic  rhinitis  showed  elevated  values
f  MPAP  and  SPAP  that  were  similar  to  those  obtained  in
atients  with  upper  airway  obstruction  due  to  adenotonsillar
ypertrophy.
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